odyssey health inc - ODYY

ODYY

Close Chg Chg %
0.05 -0.00 -5.12%

Closed Market

0.05

0.00 (5.12%)

Volume: 151.00K

Last Updated:

Dec 4, 2025, 3:05 PM EDT

Company Overview: odyssey health inc - ODYY

ODYY Key Data

Open

$0.04

Day Range

0.04 - 0.05

52 Week Range

0.01 - 0.13

Market Cap

$4.99M

Shares Outstanding

99.85M

Public Float

84.01M

Beta

-1.37

Rev. Per Employee

N/A

P/E Ratio

N/A

EPS

-$0.02

Yield

0.00%

Dividend

N/A

EX-DIVIDEND DATE

SHORT INTEREST

N/A

AVERAGE VOLUME

86.09K

 

ODYY Performance

1 Week
 
2.04%
 
1 Month
 
-30.56%
 
3 Months
 
0.40%
 
1 Year
 
81.82%
 
5 Years
 
-72.97%
 

ODYY Analyst Ratings

  • Sell
  • Under
  • Hold
  • Over
  • Buy
Number of Ratings
Full Ratings ➔

About odyssey health inc - ODYY

Odyssey Health, Inc. is a medical device technology and asset acquisition company, which engages in the development and acquisition of medical-related products. It owns heart monitoring and screening, choking rescue devices, and neurosteroid drug compounds. The company was founded in March 2014 and is headquartered in Las Vegas, NV.

ODYY At a Glance

Odyssey Health, Inc.
2300 West Sahara Avenue
Las Vegas, Nevada 89102
Phone 1-702-780-6559 Revenue 0.00
Industry Medical Specialties Net Income -1,742,691.00
Sector Health Technology Employees 2
Fiscal Year-end 07 / 2026
View SEC Filings

ODYY Valuation

P/E Current N/A
P/E Ratio (with extraordinary items) N/A
P/E Ratio (without extraordinary items) N/A
Price to Sales Ratio N/A
Price to Book Ratio N/A
Price to Cash Flow Ratio N/A
Enterprise Value to EBITDA -4.161
Enterprise Value to Sales N/A
Total Debt to Enterprise Value 0.467

ODYY Efficiency

Revenue/Employee N/A
Income Per Employee -871,345.50
Receivables Turnover N/A
Total Asset Turnover N/A

ODYY Liquidity

Current Ratio 0.007
Quick Ratio 0.007
Cash Ratio 0.003

ODYY Profitability

Gross Margin N/A
Operating Margin N/A
Pretax Margin N/A
Net Margin N/A
Return on Assets -548.129
Return on Equity N/A
Return on Total Capital 35.06
Return on Invested Capital N/A

ODYY Capital Structure

Total Debt to Total Equity N/A
Total Debt to Total Capital -39.918
Total Debt to Total Assets 3,990.417
Long-Term Debt to Equity N/A
Long-Term Debt to Total Capital N/A
  • Income Statement
  • Balance Sheet
  • Cash Flow Statement

Annual Financials for Odyssey Health Inc - ODYY

Collapse All in section
All values USD millions. 2022 2023 2024 2025 5-year trend
Sales/Revenue
- - - -
-
Sales Growth
- - - -
-
Cost of Goods Sold (COGS) incl D&A
- 2.37K 3.42K 1.54K
COGS excluding D&A
- - - -
-
Depreciation & Amortization Expense
- 2.37K 3.42K 1.54K
Depreciation
- - - 414
-
Amortization of Intangibles
- 1.96K 3.42K 1.54K
COGS Growth
-57.24% +43.89% -54.98% -100.00%
Gross Income
- (2.37K) (3.42K) (1.54K)
Gross Income Growth
+57.24% -43.89% +54.98% +100.00%
Gross Profit Margin
- - - -
-
2022 2023 2024 2025 5-year trend
SG&A Expense
8.10M 5.14M 2.14M 1.02M
Research & Development
- 1.32M 201.33K 55.17K
Other SG&A
6.79M 4.94M 2.08M 1.02M
SGA Growth
+26.33% -36.57% -58.41% -52.26%
Other Operating Expense
- - - -
-
Unusual Expense
- 170.00K 14.59M 459.42K
EBIT after Unusual Expense
(8.11M) (5.31M) (16.73M) (1.48M)
Non Operating Income/Expense
498.74K 8.68K 16.41M (10.00K)
Non-Operating Interest Income
- - - -
-
Equity in Earnings of Affiliates
- - - -
-
Interest Expense
836.29K 614.08K 518.48K 252.52K
Interest Expense Growth
-22.02% -26.57% -15.57% -51.30%
Gross Interest Expense
836.29K 614.08K 518.48K 252.52K
Interest Capitalized
- - - -
-
Pretax Income
(8.44M) (5.92M) (842.32K) (1.74M)
Pretax Income Growth
+49.98% +29.90% +85.77% -106.89%
Pretax Margin
- - - -
-
Income Tax
- - - -
-
Income Tax - Current - Domestic
- - - -
-
Income Tax - Current - Foreign
- - - -
-
Income Tax - Deferred - Domestic
- - - -
-
Income Tax - Deferred - Foreign
- - - -
-
Income Tax Credits
- - - -
-
Equity in Earnings of Affiliates
- - - -
-
Other After Tax Income (Expense)
- - - (63.45K)
-
Consolidated Net Income
(8.44M) (5.92M) (905.77K) (1.74M)
Minority Interest Expense
- - - -
-
Net Income
(8.44M) (5.92M) (905.77K) (1.74M)
Net Income Growth
+49.98% +29.90% +84.70% -92.40%
Net Margin Growth
- - - -
-
Extraordinaries & Discontinued Operations
- - - -
-
Discontinued Operations
- - - -
-
Net Income After Extraordinaries
(8.44M) (5.92M) (905.77K) (1.74M)
Preferred Dividends
- - - -
-
Net Income Available to Common
(8.44M) (5.92M) (905.77K) (1.74M)
EPS (Basic)
-0.0949 -0.0716 -0.0093 -0.0166
EPS (Basic) Growth
+47.31% +24.55% +87.01% -78.49%
Basic Shares Outstanding
89.00M 82.68M 97.06M 104.71M
EPS (Diluted)
-0.0949 -0.0716 -0.0093 -0.0166
EPS (Diluted) Growth
+47.31% +24.55% +87.01% -78.49%
Diluted Shares Outstanding
89.00M 82.68M 97.06M 104.71M
EBITDA
(8.10M) (5.14M) (2.14M) (1.02M)
EBITDA Growth
-26.33% +36.57% +58.41% +52.26%
EBITDA Margin
- - - -
-

Odyssey Health Inc in the News